These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 26788573)

  • 1. Cardiac adverse effects of nicotine replacement therapy.
    Prescrire Int; 2015 Dec; 24(166):292-3. PubMed ID: 26788573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of treatments for tobacco use disorder.
    Little MA; Ebbert JO
    Expert Opin Drug Saf; 2016; 15(3):333-41. PubMed ID: 26715118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease.
    Joseph AM; Fu SS
    Prog Cardiovasc Dis; 2003; 45(6):429-41. PubMed ID: 12800126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amfebutamone/bupropion for smoking cessation: new preparation. Nicotine replacement therapy is safer.
    Prescrire Int; 2001 Dec; 10(56):163-7. PubMed ID: 11824437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting smoking cessation.
    Larzelere MM; Williams DE
    Am Fam Physician; 2012 Mar; 85(6):591-8. PubMed ID: 22534270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline: new drug. Smoking cessation: no better than nicotine.
    Prescrire Int; 2006 Dec; 15(86):210-2. PubMed ID: 17165237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cigarettes and smoking cessation. Similar efficacy to other nicotine delivery devices, but many uncertainties.
    Prescrire Int; 2015 Nov; 24(165):271-6. PubMed ID: 26688909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of varenicline in patients with cardiovascular disease.
    Haber SL; Boomershine V; Raney E
    J Pharm Pract; 2014 Feb; 27(1):65-70. PubMed ID: 24080536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of bupropion for smoking cessation.
    Richmond R; Zwar N
    Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of pharmacological therapy for nicotine addiction in smokers following a smoking cessation program.
    Barrueco M; Otero MJ; Palomo L; Jiménez-Ruiz C; Torrecilla M; Romero P; Riesco JA
    Nicotine Tob Res; 2005 Jun; 7(3):335-42. PubMed ID: 16085501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.
    Graham DJ; By K; McKean S; Mosholder A; Kornegay C; Racoosin JA; Young J; Levenson M; MaCurdy TE; Worrall C; Kelman JA
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1205-12. PubMed ID: 25044169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
    Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB
    N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.
    Meyer TE; Taylor LG; Xie S; Graham DJ; Mosholder AD; Williams JR; Moeny D; Ouellet-Hellstrom RP; Coster TS
    Addiction; 2013 Jan; 108(1):203-10. PubMed ID: 22812921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial.
    Tulloch H; Pipe A; Els C; Aitken D; Clyde M; Corran B; Reid RD
    Contemp Clin Trials; 2014 Jul; 38(2):304-13. PubMed ID: 24861558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D; Tappenden P; Peters J; Kenjegalieva K
    Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany].
    Bergmann L; Warncke W; Herschel M
    Pneumologie; 2004 Mar; 58(3):140-6. PubMed ID: 15007784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.